The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)

Article ID	Journal	Published Year	Pages	File Type
9961087	Journal of the American College of Cardiology	2005	9 Pages	PDF

Abstract

The unknown mutation at the ARVD5 locus causing ARVC results in high mortality. Risk stratification using genetic haplotyping and ICD therapy produced improved survival for males.

Keywords

LVE SAECG SCD ARVD ARVC Signal-averaged electrocardiogram ECG electrocardiogram MRI left ventricular enlargement Ventricular tachycardia Magnetic resonance imaging ICD Arrhythmogenic right ventricular dysplasia High risk Low risk Sudden cardiac death Unknown Holter monitoring Arrhythmogenic right ventricular cardiomyopathy Implantable cardioverter-defibrillator

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)

Authors

Kathy A. MSc, Patrick S. MD, FRCPC, FACP, Anne S. MD, FRCPC, Christine MD, Jörg MD, Mark W. MD, MRCP, Ludwig MD, Susan N. MSc, Elizabeth L. MSc, William J. MD, FRCP, Sean P. MD, DPhil, FRCPC,